In-hospital Mortality Rates in SARS-CoV-2 Patients Treated with Enoxaparin and Heparin
Аbstrасt Objectives This study aimed to investigate in-hospital mortality rates in patients with coronavirus disease (COVID-19) according to enoxaparin and heparin use. Methods This retrospective cohort study included 962 patients admitted to two hospitals in Kuwait with a confirmed diagnosis of COV...
Main Authors: | Moudhi Alroomi MD, Ahmad Alsaber MD, Bader Al-Bader MD, Farah Almutairi MD, Haya Malhas MD, Jiazhu Pan MD, Kobalava D. Zhanna MD, Maryam Ramadhan MD, Mohammad Al Saleh MD, Mohammed Abdullah MD, Naser Alotaibi MD, Noor AlNasrallah MD, Rajesh Rajan MD, Soumoud Hussein MD, Wael Aboelhassan MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-10-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/10760296221131802 |
Similar Items
-
Ferritin level: A predictor of severity and mortality in hospitalized COVID‐19 patients
by: Moudhi Alroomi, et al.
Published: (2021-12-01) -
In‐hospital mortality in SARS‐CoV‐2 stratified by hemoglobin levels: A retrospective study
by: Mohammed Al‐Jarallah, et al.
Published: (2021-08-01) -
Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
by: Fakiha Siddiqui BDS, et al.
Published: (2020-01-01) -
Heparin-Induced Thrombocytopenia in Chronic Hemodialysis Patients
by: Rachelle Hamadi MD, et al.
Published: (2023-05-01) -
Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
by: Joseph Lewis BA, et al.
Published: (2022-05-01)